{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:20:44Z","timestamp":1779909644229,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM153364"],"award-info":[{"award-number":["GM153364"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM153364"],"award-info":[{"award-number":["GM153364"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM153364"],"award-info":[{"award-number":["GM153364"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM153364"],"award-info":[{"award-number":["GM153364"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM153364"],"award-info":[{"award-number":["GM153364"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA023074"],"award-info":[{"award-number":["CA023074"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"DOI":"10.1007\/s00775-025-02119-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:03:59Z","timestamp":1751367839000},"page":"443-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disulfide-based 2-pyridyl-hydrazone prochelators induce iron deprivation and oxidative stress in ovarian cancer cells"],"prefix":"10.1007","volume":"30","author":[{"given":"Jacob B.","family":"Fussell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake P.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison A.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shien","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Hua","family":"Jheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V.","family":"Astashkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Tomat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2119_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13:342\u2013355","journal-title":"Nat Rev Cancer"},{"key":"2119_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.778492","volume":"11","author":"Q Guo","year":"2021","unstructured":"Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W, Zheng L, Li X (2021) The role of iron in cancer progression. Front Oncol 11:778492","journal-title":"Front Oncol"},{"key":"2119_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ijms20020273","volume":"20","author":"M Jung","year":"2019","unstructured":"Jung M, Mertens C, Tomat E, Br\u00fcne B (2019) Iron as a central player and promising target in cancer progression. Int J Mol Sci 20:273","journal-title":"Int J Mol Sci"},{"key":"2119_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2018.07.015","volume":"133","author":"S Recalcati","year":"2019","unstructured":"Recalcati S, Gammella E, Cairo G (2019) Dysregulation of iron metabolism in cancer stem cells. Free Radic Biol Med 133:216\u2013220","journal-title":"Free Radic Biol Med"},{"key":"2119_CR5","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1039\/C9CS00373H","volume":"49","author":"A Steinbrueck","year":"2020","unstructured":"Steinbrueck A, Sedgwick AC, Brewster JT, Yan K-C, Shang Y, Knoll DM, Vargas-Z\u00fa\u00f1iga GI, He X-P, Tian H, Sessler JL (2020) Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents. Chem Soc Rev 49:3726\u20133747","journal-title":"Chem Soc Rev"},{"key":"2119_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2023.102315","volume":"74","author":"E Tomat","year":"2023","unstructured":"Tomat E (2023) Targeting iron to contrast cancer progression. Curr Opin Chem Biol 74:102315","journal-title":"Curr Opin Chem Biol"},{"key":"2119_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bbagen.2008.04.003","volume":"1790","author":"DR Richardson","year":"2009","unstructured":"Richardson DR, Kalinowski DS, Lau S, Jansson PJ, Lovejoy DB (2009) Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 1790:702\u2013717","journal-title":"Biochim Biophys Acta"},{"key":"2119_CR8","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1021\/jm900552r","volume":"52","author":"Y Yu","year":"2009","unstructured":"Yu Y, Kalinowski DS, Kovacevic Z, Siafakas AR, Jansson PJ, Stefani C, Lovejoy DB, Sharpe PC, Bernhardt PV, Richardson DR (2009) Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors. J Med Chem 52:5271\u20135294","journal-title":"J Med Chem"},{"key":"2119_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1089\/ars.2017.7487","volume":"30","author":"P Heffeter","year":"2019","unstructured":"Heffeter P, Pape VFS, Enyedy \u00c9A, Keppler BK, Szakacs G, Kowol CR (2019) Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development. Antioxid Redox Signal 30:1062\u20131082","journal-title":"Antioxid Redox Signal"},{"key":"2119_CR10","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fonc.2019.01067","volume":"9","author":"CA Kunos","year":"2019","unstructured":"Kunos CA, Andrews SJ, Moore KN, Chon HS, Ivy SP (2019) Randomized phase II trial of triapine-cisplatin-radiotherapy for locally advanced stage uterine cervix or vaginal cancers. Front Oncol 9:1067","journal-title":"Front Oncol"},{"key":"2119_CR11","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"2007","unstructured":"Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Oxford University Press, Oxford\/New York"},{"key":"2119_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273\u2013285","journal-title":"Cell"},{"key":"2119_CR13","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1039\/b708133b","volume":"30","author":"PV Bernhardt","year":"2007","unstructured":"Bernhardt PV (2007) Coordination chemistry and biology of chelators for the treatment of iron overload disorders. Dalton Trans 30:3214\u20133220","journal-title":"Dalton Trans"},{"key":"2119_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.freeradbiomed.2010.12.004","volume":"50","author":"P Ha\u0161kov\u00e1","year":"2011","unstructured":"Ha\u0161kov\u00e1 P, Kova\u0159\u00edkov\u00e1 P, Koubkov\u00e1 L, V\u00e1vrov\u00e1 A, Mackov\u00e1 E, \u0160im\u016fnek T (2011) Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity. Free Radic Biol Chem 50:537\u2013549","journal-title":"Free Radic Biol Chem"},{"key":"2119_CR15","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1158\/0008-5472.CAN-11-1218","volume":"71","author":"DB Lovejoy","year":"2011","unstructured":"Lovejoy DB, Jansson PJ, Brunk UT, Wong J, Ponka P, Richardson DR (2011) Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes. Cancer Res 71:5871","journal-title":"Cancer Res"},{"key":"2119_CR16","doi-asserted-by":"publisher","first-page":"14758","DOI":"10.1021\/jacs.2c05355","volume":"144","author":"E Falcone","year":"2022","unstructured":"Falcone E, Ritacca AG, Hager S, Schueffl H, Vileno B, El Khoury Y, Hellwig P, Kowol CR, Heffeter P, Sicilia E, Faller P (2022) Copper-catalyzed glutathione oxidation is accelerated by the anticancer thiosemicarbazone Dp44mT and further boosted at lower pH. J Am Chem Soc 144:14758\u201314768","journal-title":"J Am Chem Soc"},{"key":"2119_CR17","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1039\/C4MT00153B","volume":"6","author":"EA Akam","year":"2014","unstructured":"Akam EA, Chang TM, Astashkin AV, Tomat E (2014) Intracellular reduction\/activation of a disulfide switch in thiosemicarbazone iron chelators. Metallomics 6:1905\u20131912","journal-title":"Metallomics"},{"key":"2119_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jinorgbio.2017.12.016","volume":"180","author":"EA Akam","year":"2018","unstructured":"Akam EA, Utterback RD, Marcero JR, Dailey HA, Tomat E (2018) Disulfide-masked iron prochelators: effects on cell death, proliferation, and hemoglobin production. J Inorg Biochem 180:186\u2013193","journal-title":"J Inorg Biochem"},{"key":"2119_CR19","doi-asserted-by":"publisher","first-page":"19974","DOI":"10.1021\/acs.inorgchem.2c03250","volume":"61","author":"W Wu","year":"2022","unstructured":"Wu W, Sung Y-S, Tomat E (2022) Thiol-reactive arylsulfonate masks for phenolate donors in antiproliferative iron prochelators. Inorg Chem 61:19974\u201319982","journal-title":"Inorg Chem"},{"key":"2119_CR20","doi-asserted-by":"publisher","first-page":"15197","DOI":"10.1021\/jacs.3c02033","volume":"145","author":"ZF Xu","year":"2023","unstructured":"Xu ZF, Sung YS, Tomat E (2023) Design of tetrazolium cations for the release of antiproliferative formazan chelators in mammalian cells. J Am Chem Soc 145:15197\u201315206","journal-title":"J Am Chem Soc"},{"key":"2119_CR21","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1039\/D4CC01523A","volume":"60","author":"YS Sung","year":"2024","unstructured":"Sung YS, Tomat E (2024) Quinoline-based tetrazolium prochelators: formazan release, iron sequestration, and antiproliferative efficacy in cancer cells. Chem Commun 60:6150\u20136153","journal-title":"Chem Commun"},{"key":"2119_CR22","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1021\/jm9014394","volume":"53","author":"H Huang","year":"2010","unstructured":"Huang H, Chen Q, Ku X, Meng L, Lin L, Wang X, Zhu C, Wang Y, Chen Z, Li M, Jiang H, Chen K, Ding J, Liu H (2010) A series of \u03b1-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase II\u03b1 catalytic activity. J Med Chem 53:3048\u20133064","journal-title":"J Med Chem"},{"key":"2119_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00775-019-01675-0","volume":"24","author":"S Plamthottam","year":"2019","unstructured":"Plamthottam S, Sun D, Van Valkenburgh J, Valenzuela J, Ruehle B, Steele D, Poddar S, Marshalik M, Hernandez S, Radu CG, Zink JI (2019) Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs. J Biol Inorg Chem 24:621\u2013632","journal-title":"J Biol Inorg Chem"},{"key":"2119_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jinorgbio.2016.05.012","volume":"162","author":"V Oliveri","year":"2016","unstructured":"Oliveri V, Vecchio G (2016) Prochelator strategies for site-selective activation of metal chelators. J Inorg Biochem 162:31\u201343","journal-title":"J Inorg Biochem"},{"key":"2119_CR25","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1021\/acs.bioconjchem.6b00332","volume":"27","author":"EA Akam","year":"2016","unstructured":"Akam EA, Tomat E (2016) Targeting iron in colon cancer via glycoconjugation of thiosemicarbazone prochelators. Bioconjugate Chem 27:1807\u20131812","journal-title":"Bioconjugate Chem"},{"key":"2119_CR26","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1021\/acsmedchemlett.2c00250","volume":"13","author":"Y-S Sung","year":"2022","unstructured":"Sung Y-S, Kerimoglu B, Ooi A, Tomat E (2022) Aroylhydrazone glycoconjugate prochelators exploit glucose transporter 1 (GLUT1) to target iron in cancer cells. ACS Med Chem Lett 13:1452\u20131458","journal-title":"ACS Med Chem Lett"},{"key":"2119_CR27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1515\/hsz-2016-0336","volume":"398","author":"S Rockfield","year":"2017","unstructured":"Rockfield S, Raffel J, Mehta R, Rehman N, Nanjundan M (2017) Iron overload and altered iron metabolism in ovarian cancer. Biol Chem 398:995\u20131007","journal-title":"Biol Chem"},{"key":"2119_CR28","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/onc.2017.11","volume":"36","author":"D Basuli","year":"2017","unstructured":"Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G, Xian W, McKeon F, Lynch M, Crum CP, Hegde P, Brewer M, Wang X, Miller LD, Dyment N, Torti FM, Torti SV (2017) Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene 36:4089\u20134099","journal-title":"Oncogene"},{"key":"2119_CR29","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1158\/0008-5472.CAN-22-1294","volume":"82","author":"HI Atiya","year":"2022","unstructured":"Atiya HI, Frisbie L, Goldfeld E, Orellana T, Donnellan N, Modugno F, Calderon M, Watkins S, Zhang R, Elishaev E, Soong TR, Vlad A, Coffman L (2022) Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation. Cancer Res 82:4680\u20134693","journal-title":"Cancer Res"},{"key":"2119_CR30","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1158\/2159-8290.CD-23-1451","volume":"14","author":"TA Sandoval","year":"2024","unstructured":"Sandoval TA, Salvagno C, Chae C-S, Awasthi D, Giovanelli P, Marin Falco M, Hwang S-M, Teran-Cabanillas E, Suominen L, Yamazaki T, Kuo H-H, Moyer JE, Martin ML, Manohar J, Kim K, Sierra MA, Ramos Y, Tan C, Emmanuelli A, Song M, Morales DK, Zamarin D, Frey MK, Cantillo E, Chapman-Davis E, Holcomb K, Mason CE, Galluzzi L, Ni Zhou Z, V\u00e4h\u00e4rautio A, Cloonan SM, Cubillos-Ruiz JR (2024) Iron chelation therapy elicits innate immune control of metastatic ovarian cancer. Cancer Discov 14:1901\u20131921","journal-title":"Cancer Discov"},{"key":"2119_CR31","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1039\/c3dt50824b","volume":"42","author":"TM Chang","year":"2013","unstructured":"Chang TM, Tomat E (2013) Disulfide\/thiol switches in thiosemicarbazone ligands for redox-directed iron chelation. Dalton Trans 42:7846\u20137849","journal-title":"Dalton Trans"},{"key":"2119_CR32","doi-asserted-by":"publisher","first-page":"11377","DOI":"10.1021\/acs.inorgchem.0c01120","volume":"59","author":"AV Astashkin","year":"2020","unstructured":"Astashkin AV, Utterback RD, Sung Y-S, Tomat E (2020) Iron complexes of an antiproliferative aroyl hydrazone: characterization of three protonation states by electron paramagnetic resonance methods. Inorg Chem 59:11377\u201311384","journal-title":"Inorg Chem"},{"key":"2119_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0020-1693(98)00354-5","volume":"285","author":"JC Noveron","year":"1999","unstructured":"Noveron JC, Herradora R, Olmstead MM, Mascharak PK (1999) Low-spin iron(III) complexes with N,S coordination: syntheses, structures, and properties of bis(N-2-mercaptophenyl-2\u2019-pyridylmethyleniminato)iron(III) tetraphenylborate and bis(N-2-mercapto-2-methylpropyl-2\u2019-pyridylmethyleniminato)iron(III) tetraphenylborate. Inorg Chim Acta 285:269\u2013276","journal-title":"Inorg Chim Acta"},{"key":"2119_CR34","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1002\/cmdc.202100278","volume":"16","author":"Y-S Sung","year":"2021","unstructured":"Sung Y-S, Wu W, Ewbank MA, Utterback RD, Marty MT, Tomat E (2021) Albumin conjugates of thiosemicarbazone and imidazole-2-thione prochelators: iron coordination and antiproliferative activity. ChemMedChem 16:2764\u20132768","journal-title":"ChemMedChem"},{"key":"2119_CR35","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1021\/jm801585u","volume":"52","author":"DR Richardson","year":"2009","unstructured":"Richardson DR, Kalinowski DS, Richardson V, Sharpe PC, Lovejoy DB, Islam M, Bernhardt PV (2009) 2-acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity. J Med Chem 52:1459\u20131470","journal-title":"J Med Chem"},{"key":"2119_CR36","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1021\/jm0606342","volume":"49","author":"DR Richardson","year":"2006","unstructured":"Richardson DR, Sharpe PC, Lovejoy DB, Senaratne D, Kalinowski DS, Islam M, Bernhardt PV (2006) Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity. J Med Chem 49:6510\u20136521","journal-title":"J Med Chem"},{"key":"2119_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.phrs.2015.08.013","volume":"100","author":"PJ Jansson","year":"2015","unstructured":"Jansson PJ, Kalinowski DS, Lane DJR, Kovacevic Z, Seebacher NA, Fouani L, Sahni S, Merlot AM, Richardson DR (2015) The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the \u201cTriad of Death\u201d in cancer by Di-2-pyridylketone thiosemicarbazones. Pharmacol Res 100:255\u2013260","journal-title":"Pharmacol Res"},{"key":"2119_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/abio.1996.0032","volume":"233","author":"ZI Cabantchik","year":"1996","unstructured":"Cabantchik ZI, Glickstein H, Milgram P, Breuer W (1996) A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal Biochem 233:221\u2013227","journal-title":"Anal Biochem"},{"key":"2119_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142:24\u201338","journal-title":"Cell"},{"key":"2119_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1042\/bj3570241","volume":"357","author":"K Orino","year":"2001","unstructured":"Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM (2001) Ferritin and the response to oxidative stress. Biochem J 357:241\u2013247","journal-title":"Biochem J"},{"key":"2119_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0891-5849(02)00842-0","volume":"33","author":"P Arosio","year":"2002","unstructured":"Arosio P, Levi S (2002) Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Chem 33:457\u2013463","journal-title":"Free Radic Biol Chem"},{"key":"2119_CR42","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","volume":"30","author":"FQ Schafer","year":"2001","unstructured":"Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple. Free Radic Biol Med 30:1191\u20131212","journal-title":"Free Radic Biol Med"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-025-02119-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00775-025-02119-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-025-02119-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:36:22Z","timestamp":1757208982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00775-025-02119-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":42,"journal-issue":{"issue":"4-5","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2119"],"URL":"https:\/\/doi.org\/10.1007\/s00775-025-02119-8","relation":{},"ISSN":["1432-1327"],"issn-type":[{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}